Skip to Content

Selective phosphodiesterase-4 inhibitors

What are Selective phosphodiesterase-4 inhibitors?

Selective phosphodiesterase-4 inhibitors increase cyclic adenosine-3′,5′-monophosphate (cAMP) levels, resulting in a broad spectrum of anti-inflammatory effects in almost all inflammatory cells. Selective phosphodiesterase-4 inhibitors are used in the treatment of severe Chronic Obstructive Pulmonary Disease (COPD) to reduce the risk of COPD exacerbations. They are not bronchodilators and therefore not indicated for the relief of acute bronchospasm.

List of Selective phosphodiesterase-4 inhibitors:

View by  Brand | Generic
Drug Name Reviews Avg. Ratings
Daliresp (Pro)
Generic name: roflumilast
55 reviews
7.0
For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective).

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

See Also

Medical conditions associated with selective phosphodiesterase-4 inhibitors: